NASDAQ:QTRX - Quanterix Stock Price, Price Target & More

Sign in or create an account to add this stock to your watchlist.
$20.08 +0.43 (+2.19 %)
(As of 05/20/2018 04:00 PM ET)
Previous Close$20.08
Today's Range$19.26 - $20.50
52-Week Range$15.30 - $24.81
Volume67,188 shs
Average Volume61,118 shs
Market Capitalization$440.96 million
P/E Ratio-2.42
Dividend YieldN/A
BetaN/A

About Quanterix (NASDAQ:QTRX)

Quanterix logoQuanterix Corporation, a life sciences company, develops and markets ultra-sensitive digital immunoassay platform that advances precision health for life sciences research and diagnostics in North America, Europe, the Middle East, Africa, and the Asia Pacific. It develops Simoa HD-1 Analyzer, a sensitive protein detection platform, which analyzes approximately six biomarkers per test; and Quanterix SR-X, which utilizes the same technology and assay kit as the Simoa HD-1 Analyzer. The company's products include kits, such as beads, capture and detector reagents, enzyme reagents, and enzyme substrates to run tests; and consumables, such as proprietary Simoa disks, cuvettes, and disposable tips. In addition, it offers contract research services, including sample testing, homebrew assay development, and custom development services. The company primarily operates in the areas of neurology, oncology, cardiology, infectious diseases, and inflammation. It sell its products for the life science research sector primarily to laboratories associated with academic and governmental research institutions, as well as pharmaceutical, biotechnology, and contract research companies through a direct sales force, support organizations, and distributors or sales agents. Quanterix Corporation has a collaboration agreement with DestiNA Genomics to focus on the development of a nucleic acid assay for direct detection and quantification of the liver toxicity biomarker microRNA-122. The company was formerly known as Digital Genomics, Inc. and changed its name to Quanterix Corporation in August 2007. Quanterix Corporation was incorporated in 2007 and is headquartered in Lexington, Massachusetts.

Receive QTRX News and Ratings via Email

Sign-up to receive the latest news and ratings for QTRX and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry Analytical instruments
Sub-IndustryN/A
SectorMedical
SymbolNASDAQ:QTRX
CUSIPN/A
Phone617-301-9400

Debt

Debt-to-Equity RatioN/A
Current Ratio3.36
Quick Ratio4.35

Price-To-Earnings

Trailing P/E Ratio-2.42
Forward P/E Ratio-17.93
P/E GrowthN/A

Sales & Book Value

Annual Sales$22.87 million
Price / Sales19.28
Cash FlowN/A
Price / CashN/A
Book Value$2.70 per share
Price / Book7.44

Profitability

EPS (Most Recent Fiscal Year)N/A
Net IncomeN/A
Net MarginsN/A
Return on EquityN/A
Return on AssetsN/A

Miscellaneous

Employees126
Outstanding Shares21,960,000

Quanterix (NASDAQ:QTRX) Frequently Asked Questions

What is Quanterix's stock symbol?

Quanterix trades on the NASDAQ under the ticker symbol "QTRX."

How were Quanterix's earnings last quarter?

Quanterix Corp. (NASDAQ:QTRX) released its earnings results on Wednesday, May, 9th. The company reported ($0.33) EPS for the quarter, missing analysts' consensus estimates of ($0.25) by $0.08. View Quanterix's Earnings History.

What price target have analysts set for QTRX?

4 brokerages have issued 12 month price targets for Quanterix's stock. Their forecasts range from $26.00 to $27.00. On average, they expect Quanterix's stock price to reach $26.50 in the next year. View Analyst Ratings for Quanterix.

What are Wall Street analysts saying about Quanterix stock?

Here are some recent quotes from research analysts about Quanterix stock:
  • 1. According to Zacks Investment Research, "Quanterix Corporation is a developer of tools in high definition diagnostics. The Company focuses on research and diagnostics for brain injuries, heart disease, cancer and other diseases with its technology. It offers Simoa consumables, which include Simoa Discs, Simoa Cuvettes, Simoa Sealing Oil, Simoa Buffers and Disposable Tips. The company services include Simoa Accelerator Lab and custom assay development services. Quanterix Corporation is based in LEXINGTON, United States. " (5/15/2018)
  • 2. BTIG Research analysts commented, "Acceleration, and Expanding NT PT:1Q18 revenue growth of +41% exceeded consensus of +33% driven by strength in higher margin consumable and service revenue growth. Pharma/Biotech/CRO segment (46% of revenue) grew +48%, and Academic (46% of revenue) grew +33%. Academic should continue to strengthen with the recent launch of SR-X (1Q represented first full quarter of commercial sales; Asia launch on target for 2Q). While formal guidance for the full year remains unavailable, management is committed to delivering consensus expectations (~50% revenue growth). Looking ahead, QTRX expects to increase its sales force emphasis on the Accelerator business NT leveraging its recently acquired CLIA lab facilities (Aushon tuck-in), and in order to capitalize on the recent regulatory developments increasingly focusing on biomarker incorporation throughout biopharma preclinical/clinical trials." (5/13/2018)

Who are some of Quanterix's key competitors?

Who are Quanterix's key executives?

Quanterix's management team includes the folowing people:
  • Mr. E. Kevin Hrusovsky, Exec. Chairman, Pres & CEO (Age 57)
  • Dr. David R. Walt, Co-Founder, Chairman of Scientific Advisory Board & Director (Age 65)
  • Mr. Bruce J. Bal, VP of Operations, Service & Quality (Age 59)
  • Dr. Mark T. Roskey Ph.D., Sr. VP & GM of Applications & Reagents (Age 58)
  • Mr. Joseph S. Driscoll, Chief Financial Officer (Age 53)

When did Quanterix IPO?

(QTRX) raised $50 million in an initial public offering (IPO) on Thursday, December 7th 2017. The company issued 3,300,000 shares at $14.00-$16.00 per share. J.P. Morga and Leerink Partners acted as the underwriters for the IPO and BTIG and Evercore ISI were co-managers.

When does the company's lock-up period expire?

Quanterix's lock-up period expires on Tuesday, June 5th. Quanterix had issued 4,275,200 shares in its initial public offering on December 7th. The total size of the offering was $64,128,000 based on an initial share price of $15.00. After the end of the company's lock-up period, restrictions preventing company insiders and major shareholders from selling shares in the company will be lifted.

Has Quanterix been receiving favorable news coverage?

News coverage about QTRX stock has been trending somewhat positive this week, Accern Sentiment reports. The research firm ranks the sentiment of press coverage by monitoring more than 20 million news and blog sources. Accern ranks coverage of companies on a scale of -1 to 1, with scores closest to one being the most favorable. Quanterix earned a media sentiment score of 0.08 on Accern's scale. They also gave media stories about the company an impact score of 47.92 out of 100, indicating that recent press coverage is somewhat unlikely to have an effect on the stock's share price in the next several days.

Who are Quanterix's major shareholders?

Quanterix's stock is owned by a variety of of retail and institutional investors. Top institutional investors include Park West Asset Management LLC (0.95%), BlackRock Inc. (0.92%), Millennium Management LLC (0.73%), Opaleye Management Inc. (0.68%), Northern Trust Corp (0.24%) and Citadel Advisors LLC (0.12%). Company insiders that own Quanterix stock include David R Walt, E Kevin Hrusovsky and Venture Fund Viii Overage Arch. View Institutional Ownership Trends for Quanterix.

Which major investors are selling Quanterix stock?

QTRX stock was sold by a variety of institutional investors in the last quarter, including Millennium Management LLC and Park West Asset Management LLC. View Insider Buying and Selling for Quanterix.

Which major investors are buying Quanterix stock?

QTRX stock was purchased by a variety of institutional investors in the last quarter, including BlackRock Inc., Opaleye Management Inc., Northern Trust Corp, Citadel Advisors LLC, Schwab Charles Investment Management Inc. and California State Teachers Retirement System. Company insiders that have bought Quanterix stock in the last two years include David R Walt, E Kevin Hrusovsky and Venture Fund Viii Overage Arch. View Insider Buying and Selling for Quanterix.

How do I buy shares of Quanterix?

Shares of QTRX can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Quanterix's stock price today?

One share of QTRX stock can currently be purchased for approximately $20.08.

How big of a company is Quanterix?

Quanterix has a market capitalization of $440.96 million and generates $22.87 million in revenue each year. The company earns $-27,010,000.00 in net income (profit) each year or ($8.30) on an earnings per share basis. Quanterix employs 126 workers across the globe.

How can I contact Quanterix?

Quanterix's mailing address is 113 HARTWELL AVENUE, LEXINGTON MA, 02421. The company can be reached via phone at 617-301-9400.


MarketBeat Community Rating for Quanterix (QTRX)

Community Ranking:  2.6 out of 5 (star star)
Outperform Votes:  58 (Vote Outperform)
Underperform Votes:  55 (Vote Underperform)
Total Votes:  113
MarketBeat's community ratings are surveys of what our community members think about Quanterix and other stocks. Vote "Outperform" if you believe QTRX will outperform the S&P 500 over the long term. Vote "Underperform" if you believe QTRX will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Quanterix (NASDAQ:QTRX) Price Target and Consensus Rating

  (How are Consensus Ratings Calculated?)
4 Wall Street analysts have issued ratings and price targets for Quanterix in the last 12 months. Their average twelve-month price target is $26.50, suggesting that the stock has a possible upside of 31.97%. The high price target for QTRX is $27.00 and the low price target for QTRX is $26.00. There are currently 4 buy ratings for the stock, resulting in a consensus rating of "Buy."
Today30 Days Ago90 Days Ago180 Days Ago
Consensus Rating: BuyBuyBuyN/A
Consensus Rating Score: 3.003.003.00N/A
Ratings Breakdown: 0 Sell Rating(s)
0 Hold Rating(s)
4 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
0 Hold Rating(s)
4 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
0 Hold Rating(s)
4 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
0 Hold Rating(s)
0 Buy Rating(s)
0 Strong Buy Rating(s)
Consensus Price Target: $26.50$26.50$26.50N/A
Price Target Upside: 31.97% upside23.43% upside23.43% upsideN/A

Quanterix (NASDAQ:QTRX) Consensus Price Target History

Price Target History for Quanterix (NASDAQ:QTRX)

Quanterix (NASDAQ:QTRX) Analyst Ratings History

Show:
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
5/13/2018BTIG ResearchReiterated RatingBuy$26.00MediumView Rating Details
1/2/2018Leerink SwannInitiated CoverageOutperform ➝ Outperform$27.00HighView Rating Details
1/2/2018CowenInitiated CoverageOutperformHighView Rating Details
1/2/2018JPMorgan ChaseInitiated CoverageOverweight ➝ OverweightHighView Rating Details
(Data available from 5/20/2016 forward)

Earnings

Quanterix (NASDAQ:QTRX) Earnings History and Estimates Chart

Earnings by Quarter for Quanterix (NASDAQ:QTRX)

Quanterix (NASDAQ:QTRX) Earnings Estimates

2018 EPS Consensus Estimate: ($1.07)
2019 EPS Consensus Estimate: ($0.42)
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20181($0.23)($0.23)($0.23)
Q2 20181($0.28)($0.28)($0.28)
Q3 20181($0.28)($0.28)($0.28)
Q4 20181($0.28)($0.28)($0.28)
Q1 20191($0.18)($0.18)($0.18)
Q2 20191($0.10)($0.10)($0.10)
Q3 20191($0.10)($0.10)($0.10)
Q4 20191($0.04)($0.04)($0.04)

Quanterix (NASDAQ QTRX) Earnings History by Quarter

DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
5/9/2018Q1 2018($0.25)($0.33)ViewN/AView Earnings Details
3/19/2018Q4 2017($0.30)($1.06)$6.81 million$6.59 millionViewN/AView Earnings Details
(Earnings results data provided by Zacks Investment Research)

Dividends

Quanterix (NASDAQ:QTRX) Dividend History by Quarter

AnnouncedPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
(Data available from 1/1/2013 forward)

Insider Trades

Quanterix (NASDAQ QTRX) Insider Trading and Institutional Ownership History

Institutional Ownership Percentage: 45.89%
Insider Trading History for Quanterix (NASDAQ:QTRX)
Institutional Ownership by Quarter for Quanterix (NASDAQ:QTRX)

Quanterix (NASDAQ QTRX) Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
12/11/2017David R WaltDirectorBuy200,000$15.00$3,000,000.00View SEC Filing  
12/11/2017E Kevin HrusovskyInsiderBuy34,000$15.00$510,000.00View SEC Filing  
12/11/2017Venture Fund Viii Overage ArchMajor ShareholderBuy266,000$15.00$3,990,000.00View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

Quanterix (NASDAQ QTRX) News Headlines

Source:
DateHeadline
Quanterix Corp. (QTRX) Expected to Post Quarterly Sales of $7.25 MillionQuanterix Corp. (QTRX) Expected to Post Quarterly Sales of $7.25 Million
www.americanbankingnews.com - May 20 at 2:10 AM
Financial Review: Quanterix (QTRX) & Bruker (BRKR)Financial Review: Quanterix (QTRX) & Bruker (BRKR)
www.americanbankingnews.com - May 20 at 1:18 AM
Quanterix Corp. (QTRX) Expected to Post Earnings of -$0.28 Per ShareQuanterix Corp. (QTRX) Expected to Post Earnings of -$0.28 Per Share
www.americanbankingnews.com - May 18 at 9:24 PM
Quanterix (QTRX) Lowered to "Sell" at Zacks Investment ResearchQuanterix (QTRX) Lowered to "Sell" at Zacks Investment Research
www.americanbankingnews.com - May 15 at 2:09 PM
Quanterix Corp. (QTRX) Receives Consensus Rating of "Buy" from BrokeragesQuanterix Corp. (QTRX) Receives Consensus Rating of "Buy" from Brokerages
www.americanbankingnews.com - May 15 at 11:27 AM
Quanterix Corp. (QTRX) Forecasted to Post Q2 2018 Earnings of ($0.28) Per ShareQuanterix Corp. (QTRX) Forecasted to Post Q2 2018 Earnings of ($0.28) Per Share
www.americanbankingnews.com - May 14 at 1:56 AM
BTIG Research Reaffirms Buy Rating for Quanterix (QTRX)BTIG Research Reaffirms Buy Rating for Quanterix (QTRX)
www.americanbankingnews.com - May 13 at 7:54 AM
Quanterixs (QTRX) CEO Kevin Hrusovsky on Q1 2018 Results - Earnings Call TranscriptQuanterix's (QTRX) CEO Kevin Hrusovsky on Q1 2018 Results - Earnings Call Transcript
seekingalpha.com - May 10 at 10:39 AM
Quanterix Corporation Releases Operating Results for First Quarter 2018Quanterix Corporation Releases Operating Results for First Quarter 2018
finance.yahoo.com - May 10 at 10:38 AM
Quanterix (QTRX) Releases  Earnings ResultsQuanterix (QTRX) Releases Earnings Results
www.americanbankingnews.com - May 10 at 12:50 AM
 Analysts Set $25.67 Price Target for Quanterix Corp. (QTRX) Analysts Set $25.67 Price Target for Quanterix Corp. (QTRX)
www.americanbankingnews.com - May 7 at 3:30 AM
Quanterix (QTRX) to Release Earnings on WednesdayQuanterix (QTRX) to Release Earnings on Wednesday
www.americanbankingnews.com - May 3 at 10:24 AM
Quanterix Corp. (QTRX) Expected to Post Quarterly Sales of $7.09 MillionQuanterix Corp. (QTRX) Expected to Post Quarterly Sales of $7.09 Million
www.americanbankingnews.com - May 3 at 4:20 AM
Quanterix to Release First Quarter 2018 Financial Results and Host Conference Call on Wednesday, May 9, 2018Quanterix to Release First Quarter 2018 Financial Results and Host Conference Call on Wednesday, May 9, 2018
finance.yahoo.com - May 2 at 10:09 AM
-$0.26 EPS Expected for Quanterix Corp. (QTRX) This Quarter-$0.26 EPS Expected for Quanterix Corp. (QTRX) This Quarter
www.americanbankingnews.com - May 1 at 9:18 AM
Quanterix Marks Leadership in Accelerating Neurology Research with 100-Publication MilestoneQuanterix Marks Leadership in Accelerating Neurology Research with 100-Publication Milestone
finance.yahoo.com - April 27 at 10:54 AM
 Quanterix Corp. (QTRX) Given $25.67 Consensus Price Target by Analysts Quanterix Corp. (QTRX) Given $25.67 Consensus Price Target by Analysts
www.americanbankingnews.com - April 21 at 9:18 AM
Zacks: Analysts Expect Quanterix Corp (QTRX) Will Post Quarterly Sales of $7.09 MillionZacks: Analysts Expect Quanterix Corp (QTRX) Will Post Quarterly Sales of $7.09 Million
www.americanbankingnews.com - April 16 at 3:58 AM
Quanterix Corp (QTRX) Expected to Post Earnings of -$0.26 Per ShareQuanterix Corp (QTRX) Expected to Post Earnings of -$0.26 Per Share
www.americanbankingnews.com - April 14 at 9:17 AM
FY2018 Earnings Forecast for Quanterix Corp (QTRX) Issued By Leerink SwannFY2018 Earnings Forecast for Quanterix Corp (QTRX) Issued By Leerink Swann
www.americanbankingnews.com - April 9 at 1:54 AM
Analyzing Bio-Rad Laboratories (BIO) & Quanterix (QTRX)Analyzing Bio-Rad Laboratories (BIO) & Quanterix (QTRX)
www.americanbankingnews.com - April 6 at 10:09 AM
Leerink Swann Weighs in on Quanterix Corps FY2020 Earnings (QTRX)Leerink Swann Weighs in on Quanterix Corp's FY2020 Earnings (QTRX)
www.americanbankingnews.com - April 6 at 8:23 AM
 Quanterix Corp (QTRX) Receives Average Rating of "Strong Buy" from Brokerages Quanterix Corp (QTRX) Receives Average Rating of "Strong Buy" from Brokerages
www.americanbankingnews.com - April 5 at 5:28 AM
Quanterix (QTRX) Upgraded by ValuEngine to "Hold"Quanterix (QTRX) Upgraded by ValuEngine to "Hold"
www.americanbankingnews.com - April 3 at 10:07 AM
Quanterix (QTRX) Now Covered by Leerink SwannQuanterix (QTRX) Now Covered by Leerink Swann
www.americanbankingnews.com - March 31 at 11:54 AM
Quanterix (QTRX) Receives New Coverage from Analysts at BTIG ResearchQuanterix (QTRX) Receives New Coverage from Analysts at BTIG Research
www.americanbankingnews.com - March 31 at 11:54 AM
Quanterix (QTRX) Now Covered by CowenQuanterix (QTRX) Now Covered by Cowen
www.americanbankingnews.com - March 31 at 11:54 AM
JPMorgan Chase Begins Coverage on Quanterix (QTRX)JPMorgan Chase Begins Coverage on Quanterix (QTRX)
www.americanbankingnews.com - March 31 at 11:54 AM
$6.81 Million in Sales Expected for Quanterix Corp (QTRX) This Quarter$6.81 Million in Sales Expected for Quanterix Corp (QTRX) This Quarter
www.americanbankingnews.com - March 30 at 3:02 AM
Quanterix (QTRX) Presents At Needham and Company 17th Annual Healthcare Conference - SlideshowQuanterix (QTRX) Presents At Needham and Company 17th Annual Healthcare Conference - Slideshow
seekingalpha.com - March 29 at 3:46 PM
Quanterix to Present at Needham and Company’s 17th Annual Healthcare ConferenceQuanterix to Present at Needham and Company’s 17th Annual Healthcare Conference
finance.yahoo.com - March 29 at 10:47 AM
Zacks: Quanterix Corp (QTRX) Receives Average Rating of "Strong Buy" from BrokeragesZacks: Quanterix Corp (QTRX) Receives Average Rating of "Strong Buy" from Brokerages
www.americanbankingnews.com - March 21 at 3:28 AM
Quanterix Corp to Post FY2020 Earnings of $0.41 Per Share, Leerink Swann Forecasts (QTRX)Quanterix Corp to Post FY2020 Earnings of $0.41 Per Share, Leerink Swann Forecasts (QTRX)
www.americanbankingnews.com - March 19 at 9:13 AM
Quanterix (QTRX) Posts  Earnings Results, Misses Estimates By $0.04 EPSQuanterix (QTRX) Posts Earnings Results, Misses Estimates By $0.04 EPS
www.americanbankingnews.com - March 14 at 7:56 PM
Quanterix Corporation Releases Operating Results for Fourth Quarter and Fiscal Year 2017Quanterix Corporation Releases Operating Results for Fourth Quarter and Fiscal Year 2017
finance.yahoo.com - March 14 at 4:30 PM
Brokerages Anticipate Quanterix Corp (QTRX) to Post ($0.30) EPSBrokerages Anticipate Quanterix Corp (QTRX) to Post ($0.30) EPS
www.americanbankingnews.com - March 14 at 1:05 PM
$6.54 Million in Sales Expected for Quanterix Corp (QTRX) This Quarter$6.54 Million in Sales Expected for Quanterix Corp (QTRX) This Quarter
www.americanbankingnews.com - March 13 at 10:20 AM
Zacks: Analysts Anticipate Quanterix Corp (QTRX) to Announce -$0.30 Earnings Per ShareZacks: Analysts Anticipate Quanterix Corp (QTRX) to Announce -$0.30 Earnings Per Share
www.americanbankingnews.com - March 11 at 8:24 AM
Quanterix (QTRX) Set to Announce Quarterly Earnings on WednesdayQuanterix (QTRX) Set to Announce Quarterly Earnings on Wednesday
www.americanbankingnews.com - March 8 at 9:58 AM
Flagship Pioneering Inc. Buys Shares of 2,030,495 Quanterix Corp (QTRX)Flagship Pioneering Inc. Buys Shares of 2,030,495 Quanterix Corp (QTRX)
www.americanbankingnews.com - March 6 at 2:58 PM
Royce & Associates LP Takes Position in Quanterix Corp (QTRX)Royce & Associates LP Takes Position in Quanterix Corp (QTRX)
www.americanbankingnews.com - March 3 at 9:12 AM
 Quanterix Corp (QTRX) Receives Average Recommendation of "Strong Buy" from Brokerages Quanterix Corp (QTRX) Receives Average Recommendation of "Strong Buy" from Brokerages
www.americanbankingnews.com - February 25 at 3:30 PM
Quanterix Corp (QTRX) Expected to Announce Quarterly Sales of $6.54 MillionQuanterix Corp (QTRX) Expected to Announce Quarterly Sales of $6.54 Million
www.americanbankingnews.com - February 24 at 7:56 AM
 Quanterix Corp (QTRX) Given Consensus Recommendation of "Strong Buy" by Analysts Quanterix Corp (QTRX) Given Consensus Recommendation of "Strong Buy" by Analysts
www.americanbankingnews.com - February 16 at 9:28 PM
Quanterix (QTRX) Presents At Leerink Partners 7th Annual Global Healthcare Conference - SlideshowQuanterix (QTRX) Presents At Leerink Partners 7th Annual Global Healthcare Conference - Slideshow
seekingalpha.com - February 16 at 3:51 PM
Quanterix to Present at The LEERINK Partners 7th Annual Global Healthcare ConferenceQuanterix to Present at The LEERINK Partners 7th Annual Global Healthcare Conference
finance.yahoo.com - February 8 at 4:58 PM
-$0.30 EPS Expected for Quanterix Corp (QTRX) This Quarter-$0.30 EPS Expected for Quanterix Corp (QTRX) This Quarter
www.americanbankingnews.com - February 5 at 11:18 AM
 Quanterix Corp (QTRX) Given $25.67 Consensus Price Target by Brokerages Quanterix Corp (QTRX) Given $25.67 Consensus Price Target by Brokerages
www.americanbankingnews.com - January 31 at 7:20 PM
 Quanterix Corp (QTRX) Given Average Recommendation of "Strong Buy" by Brokerages Quanterix Corp (QTRX) Given Average Recommendation of "Strong Buy" by Brokerages
www.americanbankingnews.com - January 28 at 9:30 PM
Zacks: Quanterix Corp (QTRX) Given $25.67 Consensus Price Target by BrokeragesZacks: Quanterix Corp (QTRX) Given $25.67 Consensus Price Target by Brokerages
www.americanbankingnews.com - January 25 at 11:41 AM

SEC Filings

Quanterix (NASDAQ:QTRX) SEC Filings

This page is loading this company's SEC Filings. Please wait...

Social Media

Financials

Financials are not available for this stock.

Chart

Quanterix (NASDAQ QTRX) Stock Chart for Sunday, May, 20, 2018

Loading chart…

This page was last updated on 5/20/2018 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.